|
| 37964408 | Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program. | Eur J Heart Fail | 2024 |
| 37758044 | Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics. | Am Heart J | 2024 |
| 38037709 | Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials. | Eur J Heart Fail | 2024 |
| 37715769 | Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF: Post-Hoc Analysis of EMPEROR-Reduced. | JACC Heart Fail | 2024 |
| 38069915 | Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study. | Clin Chem | 2024 |
| 37878066 | The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT). | | 2024 |
| 36658423 | The impact of the COVID-19 pandemic on cardiovascular disease prevention and management. | Nat Med | 2023 |
| 35396632 | Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes. | Clinical Research in Cardiology | 2023 |
| 36181450 | Testing for association between exonic glucagon-like peptide 1 receptor mutation with physical and brain health traits in UK Biobank. | Diabetes Obes Metab | 2023 |
| 35452027 | Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study. | Pain | 2023 |
| 36224274 | Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data. | Diabetologia | 2023 |
| 35953263 | Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. | Ann Rheum Dis | 2023 |
| 36342827 | Empagliflozin in Black Versus White Patients With Heart Failure: Analysis of EMPEROR-Pooled. | Circulation | 2023 |
| 36208182 | Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2). | European Journal of Preventive Cardiology | 2023 |
| 36325584 | Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced. | Eur J Heart Fail | 2023 |
| 36442979 | Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League against Rheumatism (EULAR)'s recommendations for cardiovascular risk management? | Annals of the Rheumatic Diseases | 2023 |
| 36440921 | Care processes in people in remission from type 2 diabetes: A cohort study using the National Diabetes Audit. | Diabetic Medicine | 2023 |
| 36427190 | To ApoB or Not to ApoB: New Arguments, but Basis for Widespread Implementation Remains Elusive. | Clinical Chemistry | 2023 |
| 36398460 | Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT). | Diabetic Medicine | 2023 |
| 36315474 | Lipid Lowering in "Very High Risk" Patients Undergoing Coronary Artery Bypass Surgery and Its Projected Reduction in Risk for Recurrent Vascular Events: A Monte Carlo Stepwise Simulation Approach. | Journal of Cardiovascular Pharmacology | 2023 |
| 37756566 | Prediction of Cardiometabolic Health Through Changes in Plasma Proteins With Intentional Weight Loss in the DiRECT and DIADEM-I Randomized Clinical Trials of Type 2 Diabetes Remission. | | 2023 |
| 37603600 | Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial. | | 2023 |
| 37845826 | Challenges in undertaking nonlinear Mendelian randomization. | Obesity (Silver Spring) | 2023 |
| 38030643 | Using trials of caloric restriction and bariatric surgery to explore the effects of body mass index on the circulating proteome. | | 2023 |
| 38017465 | Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004-2015 cohort studies: no obesity paradox? | Cardiovasc Diabetol | 2023 |
| 37824793 | Predictors of â¿¥15% Weight Reduction and Associated Changes in Cardiometabolic Risk Factors With Tirzepatide in Adults With Type 2 Diabetes in SURPASS 1-4. | | 2023 |
| 37740450 | Effects of Renin-Angiotensin system blockers on outcomes from COVID-19: A systematic review and meta-analysis of randomised controlled trials. | | 2023 |
| 37917855 | Risk Factors for and Risk of Peripheral Artery Disease in Swedish Individuals With Type 2 Diabetes: A Nationwide Register-Based Study. | | 2023 |
| 37734395 | Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide study. | | 2023 |
| 37653345 | Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization. | | 2023 |
| 37724055 | Associations and predictive performance of 11 anthropometric measures with incident type 2 diabetes: A prospective cohort study from the UK Biobank. | | 2023 |
| 37889195 | Validating the SMART2 Score in a Racially Diverse High-Risk Nationwide Cohort of Patients Receiving Coronary Artery Bypass Grafting. | | 2023 |
| 37796425 | Correction to: Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England. | | 2023 |
| 38085032 | The potential benefit of statin prescription based on prediction of treatment responsiveness in older individuals: An application to the PROSPER randomised controlled trial. | | 2023 |
| 38078870 | Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. | | 2023 |
| 37556814 | Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes. | | 2023 |
| 37622663 | 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | | 2023 |
| 37620452 | Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England. | | 2023 |
| 37552540 | Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes. | JCI Insight | 2023 |
| 37865123 | Geographically Weighted Modeling to Explore Social and Environmental Factors Affecting County-Level Cardiovascular Mortality in People With Diabetes in the United States: A Cross-Sectional Analysis. | | 2023 |
| 37862463 | Incidence and determinants of spontaneous normalization of subclinical hypothyroidism in older adults. | | 2023 |
| 37156255 | Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. | | 2023 |
| 37034649 | Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications. | medRxiv | 2023 |
| 36657086 | Comparative Incidence of Diabetes Following Hospital Admission for COVID-19 and Pneumonia: A Cohort Study. | | 2023 |
| 36592046 | IGFBP-7 and Outcomes in Heart Failure With Reduced Ejection Fraction: Findings From DAPA-HF. | JACC Heart Fail | 2023 |
| 37407113 | Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure. | J Am Coll Cardiol | 2023 |
| 37154040 | Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study. | Circulation | 2023 |
| 36777452 | Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby). | | 2023 |
| 36767787 | Identifying the Biomarker Profile of Pre-Frail and Frail People: A Cross-Sectional Analysis from UK Biobank. | | 2023 |
| 36951683 | Association between walking pace and incident type 2 diabetes by adiposity level: A prospective cohort study from the UK Biobank. | | 2023 |